Loading…
Adagio Medical Holdings, Inc. is projected to decline to $0.439 by 2027, a -5% move from its current price of $0.46. ADGM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4408 | $0.4604 | $0.4808 | +0.08% |
| Aug 6 | $0.4333 | $0.4607 | $0.4899 | +0.16% |
| Aug 7 | $0.4277 | $0.4611 | $0.4971 | +0.23% |
| Aug 8 | $0.4231 | $0.4614 | $0.5033 | +0.31% |
| Aug 9 | $0.4191 | $0.4618 | $0.5089 | +0.39% |
| Aug 10 | $0.4155 | $0.4622 | $0.514 | +0.47% |
| Aug 11 | $0.4123 | $0.4625 | $0.5188 | +0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4123 | $0.4625 | $0.5188 | +0.55% |
| Week 2 | $0.3953 | $0.465 | $0.5471 | +1.10% |
| Week 3 | $0.3832 | $0.4676 | $0.5705 | +1.65% |
| Week 4 | $0.3736 | $0.4702 | $0.5916 | +2.21% |
| Week 5 | $0.3656 | $0.4727 | $0.6112 | +2.77% |
| Week 6 | $0.3587 | $0.4753 | $0.6298 | +3.33% |
| Week 7 | $0.3527 | $0.4779 | $0.6477 | +3.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Adagio Medical Holdings, Inc. is a healthcare-focused medical technology company that develops and commercializes ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia.
Its product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTA catheter; and Cryopulse pulsed field cryoablation catheters. The company was founded in 2011 and is headquartered in Laguna Hills, California.
Adagio Medical Holdings, Inc. (ADGM) is a healthcare stock with a current price of $0.3745 and a market capitalization of $8.32M. It is ranked 4858 by market cap.
The near-term outlook, based on the forecast for 2026, shows a min of $0.3745, an avg of $0.3745, and a max of $0.5256, with a 0% ROI and NEUTRAL sentiment. The 30-day technical picture shows RSI (14) at 20, a SMA50 of $0.6476, and a SMA200 of $0.9624, with a key support at $0.375 and resistance at $0.70. The 30-day price range spans $0.279 to $0.5027, indicating a relatively tight trading band around current levels.
Looking further out, the multi-year forecast suggests a bullish shift beginning in 2030, with an average price of $0.4711 and a maximum of $0.7721, reflecting a 25.8% ROI. By 2040, the average rises to $0.6051 with a $1.23 high and a 61.6% ROI, and by 2050, the average is $1.10 with a $2.51 high and a 192.7% ROI.
A major floor 62.9% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
The nearest ceiling, 48.5% above — a clean break opens room to run.
A major ceiling 254.3% above — clearing it would confirm fresh momentum.
Key ADGM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADGM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4186 | Buy | $0.4103 | Buy |
| MA 10 | $0.4484 | Buy | $0.4461 | Buy |
| MA 20 | $0.509 | Sell | $0.5021 | Sell |
| MA 50 | $0.6385 | Sell | $0.6415 | Sell |
| MA 100 | $0.8974 | Sell | $0.7917 | Sell |
| MA 200 | $0.9548 | Sell | $1.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 20.96 | Buy |
| Stoch RSI (14) | 24.81 | Neutral |
| CCI (20) | -143.88 | Sell |
| Williams %R (14) | -98.54 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -31.40 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 1.46 | Buy |
| TRIX (15) | -1.52 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 19.01 | Buy |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.38 | Buy |
| ADX (14) | 45.30 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL overall, with RSI(14) at 20 indicating potential oversold pressure amid a neutral sentiment. The stock trades with the SMA50 at $0.6476 and the SMA200 at $0.9624, suggesting the price remains below both moving averages. Support is at $0.375 and resistance at $0.70, framing the near-term upside.
The 30-day range runs from $0.279 to $0.5027, highlighting limited near-term volatility around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.375 | $0.46 | $0.6372 | 0% | Neutral | |
| $0.3315 | $0.439 | $0.6245 | -5% | Neutral | |
| $0.2884 | $0.4007 | $0.6025 | -13% | Neutral | |
| $0.3251 | $0.4704 | $0.7379 | +2% | Neutral | |
| $0.3837 | $0.5755 | $0.935 | +25% | Bullish | |
| $0.4009 | $0.6218 | $1.04 | +35% | Bullish | |
| $0.3597 | $0.5756 | $0.9902 | +25% | Bullish | |
| $0.3441 | $0.5673 | $0.9999 | +23% | Bullish | |
| $0.3389 | $0.5751 | $1.04 | +25% | Bullish | |
| $0.297 | $0.5182 | $0.9529 | +13% | Neutral | |
| $0.3749 | $0.7461 | $1.49 | +62% | Bullish | |
| $0.5984 | $1.33 | $3.00 | +189% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.375 | $0.46 | $0.5531 | +0.00% |
| September 2026 | $0.3992 | $0.4801 | $0.5991 | +4.37% |
| October 2026 | $0.4061 | $0.4939 | $0.6268 | +2.88% |
| November 2026 | $0.3918 | $0.4809 | $0.6185 | -2.64% |
| December 2026 | $0.3955 | $0.4895 | $0.6372 | +1.79% |
Click any year to see its month-by-month ADGM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ADGM is projected to trade between $0.375 and $0.6372, averaging $0.46 — a potential gain of 0% from today's $0.46. Price action looks broadly range-bound.
Adagio Medical Holdings, Inc.'s 2027 outlook centres on $0.439, within a $0.3315 to $0.6245 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, ADGM could reach as high as $0.6025, with a base case around $0.4007 and support toward $0.2884 — roughly -13% from $0.46. Price action looks broadly range-bound.
Expect ADGM to range from $0.3251 to $0.7379 through 2029. The $0.4704 average target implies a +2% move from current prices. That is up +17% on the projected 2028 average. A consolidation phase looks the most probable path here.
The ADGM price prediction for 2030 points to an average of $0.5755 (low $0.3837, high $0.935) — a potential gain of +25% on today's $0.46. Momentum favours further upside here.
In 2031, ADGM is projected to trade between $0.4009 and $1.04, averaging $0.6218 — a potential gain of +35% from today's $0.46. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Adagio Medical Holdings, Inc.'s 2032 outlook centres on $0.5756, within a $0.3597 to $0.9902 range. That is -7% versus the projected 2031 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2033, ADGM could reach as high as $0.9999, with a base case around $0.5673 and support toward $0.3441 — roughly +23% from $0.46. Buyers look set to stay in control over this stretch.
Expect ADGM to range from $0.3389 to $1.04 through 2034. The $0.5751 average target implies a +25% move from current prices. That is up +1% on the projected 2033 average. Momentum favours further upside here.
The ADGM price prediction for 2035 points to an average of $0.5182 (low $0.297, high $0.9529) — a potential gain of +13% on today's $0.46. A consolidation phase looks the most probable path here.
In 2040, ADGM is projected to trade between $0.3749 and $1.49, averaging $0.7461 — a potential gain of +62% from today's $0.46. That is up +44% on the projected 2035 average. Momentum favours further upside here.
Adagio Medical Holdings, Inc.'s 2050 outlook centres on $1.33, within a $0.5984 to $3.00 range. That is up +78% on the projected 2040 average. That marks a +189% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADGM today (≈ 2,173.913043 ADGM) could be worth
$2,891.02
+$1,891.02 (+189%) by 2050 · US Dollar
Based on the average projected ADGM price of $1.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADGMwould be worth at today's price.
$1,000 invested in ADGM on Jul 31, 2025 (≈ 757.575727 ADGM) would be worth
$348.48
-$651.52 (-65.2%) today · 0.35× · US Dollar
Based on a ADGM entry price of $1.32 vs. today's $0.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.482 | $954.36 | -4.6% |
| 1 month ago | $0.661 | $695.92 | -30.4% |
| 3 months ago | $1.03 | $446.6 | -55.3% |
| 6 months ago | $1.03 | $446.6 | -55.3% |
| 1 year ago | $1.32 | $348.48 | -65.2% |
| All time (2.0y) ago | $9.05 | $50.83 | -94.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADGM forecast.
Our base-case forecast reaches $0.92 around 2050.
Implied market cap at $0.92: $20.43M
The multi-year forecast shows a path from neutral near term to bullish longer term. In 2026, the min and avg are both $0.3745 with a max of $0.5256 and ROI of 0%, indicating a flat start with modest upside potential. The outlook turns bullish from 2030 onward, with 2030’s avg $0.4711 and max $0.7721 yielding ROI of 25.8% and a bullish sentiment.
By 2040, the avg price is $0.6051 with a max of $1.23 and ROI of 61.6%, reinforcing stronger upside momentum. The 2050 forecast shows an avg of $1.10, a max of $2.51, and a ROI of 192.7% with a bullish sentiment. While these are estimates and not guarantees, the longer-term path points to meaningful upside, tempered by near-term volatility and the risk that outcomes may differ from these projections.
Tap a question to reveal the answer.
2030 avg price is $0.4711; min $0.3112; max $0.7721; ROI 25.8%; sentiment BULLISH.
Near term shows flat to mixed performance (2026 ROI 0%; 2027 ROI -5.1%; 2028 ROI -14.3%; 2029 ROI 3.5%), while the forecast from 2030 onward is bullish with higher average prices and ROI reaching 25.8% in 2030, 61.6% in 2040, and 192.7% in 2050.
Yes. The max forecast price is $0.7721 in 2030, $1.23 in 2040, and $2.51 in 2050, so surpassing $1 is possible by 2040 based on these projections.
Current price is $0.3745 and market cap is $8.32M.
2026 forecast shows min $0.3745, avg $0.3745, max $0.5256 with ROI 0% and sentiment NEUTRAL.
Adagio Medical Holdings, Inc. Community Discussion
0Share your Adagio Medical Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.